Skip to content
10-Q

Quarterly Report

American Oncology Network, Inc.

0001628280-24-047613

← back to feed
Filed
Nov 13, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2024 · Sep 30, 2024 13.26M sh
Shares Diluted Q3 2024 · Sep 30, 2024 36.23M sh
Shares Diluted Q3 2024 · Sep 30, 2023 6.61M sh
Shares Diluted Q3 2024 · Sep 30, 2023 6.61M sh
Stock Repurchased Q3 2024 · Sep 30, 2024 $368K
Stock Repurchased Q3 2024 · Sep 30, 2023 $0
Capex Q3 2024 · Sep 30, 2024 $14.63M
Capex Q3 2024 · Sep 30, 2023 $9.53M
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$16.87M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$6.16M
Long Term Debt Q3 2024 · Sep 30, 2024 $87.63M
Long Term Debt Q3 2024 · Dec 31, 2023 $80.64M
Short Term Debt Q3 2024 · Sep 30, 2024 $3.81M
Short Term Debt Q3 2024 · Dec 31, 2023 $0
Cash And Equivalents Q3 2024 · Sep 30, 2024 $19.43M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $28.54M
Stockholders Equity Q3 2024 · Sep 30, 2024 −$103.83M
Stockholders Equity Q3 2024 · Dec 31, 2023 −$161.73M
Current Liabilities Q3 2024 · Sep 30, 2024 $199.86M
Current Liabilities Q3 2024 · Dec 31, 2023 $169.05M
Total Liabilities Q3 2024 · Sep 30, 2024 $340.72M
Total Liabilities Q3 2024 · Dec 31, 2023 $303.74M
Current Assets Q3 2024 · Sep 30, 2024 $271.23M
Current Assets Q3 2024 · Dec 31, 2023 $277.8M
Total Assets Q3 2024 · Sep 30, 2024 $394.81M
Total Assets Q3 2024 · Dec 31, 2023 $374.45M
Eps Diluted Q3 2024 · Sep 30, 2024 −$190.00
Eps Diluted Q3 2024 · Sep 30, 2024 −$940.00
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.61
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.61
Eps Basic Q3 2024 · Sep 30, 2024 −$190.00
Eps Basic Q3 2024 · Sep 30, 2024 −$900.00
Eps Basic Q3 2024 · Sep 30, 2023 −$0.61
Eps Basic Q3 2024 · Sep 30, 2023 −$0.61
Sga Expense Q3 2024 · Sep 30, 2024 $34.74M
Sga Expense Q3 2024 · Sep 30, 2024 $99.75M
Sga Expense Q3 2024 · Sep 30, 2023 $25.2M
Sga Expense Q3 2024 · Sep 30, 2023 $72.83M
Net Income Q3 2024 · Sep 30, 2024 −$389K
Net Income Q3 2024 · Sep 30, 2024 −$4.9M
Net Income Q3 2024 · Sep 30, 2023 −$1.79M
Net Income Q3 2024 · Sep 30, 2023 −$1.79M
Operating Income Q3 2024 · Sep 30, 2024 $1.6M
Operating Income Q3 2024 · Sep 30, 2024 −$25.65M
Operating Income Q3 2024 · Sep 30, 2023 −$24.39M
Operating Income Q3 2024 · Sep 30, 2023 −$28.54M
Cost Of Revenue Q3 2024 · Sep 30, 2024 $433.75M
Cost Of Revenue Q3 2024 · Sep 30, 2024 $1.19B
Cost Of Revenue Q3 2024 · Sep 30, 2023 $310.89M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $880.83M
Revenue Q3 2024 · Sep 30, 2024 $470.28M
Revenue Q3 2024 · Sep 30, 2024 $1.27B
Revenue Q3 2024 · Sep 30, 2023 $336.31M
Revenue Q3 2024 · Sep 30, 2023 $955M